HNGE vs MRNA · rev $587.9M vs rev $145.0M
Hinge Health, Inc. (HNGE) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Hinge Health, Inc. (HNGE) is a health information services company listed on NYSE.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported HNGE revenue for 2025-12-31 was $587.9M. Net income was -$528.3M. Revenue was up 50.6% from 2024-12-31 to 2025-12-31. HNGE currently screens at market cap $5.29B.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
HNGE currently screens at market cap $5.29B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the HNGE and MRNA stock pages for the full models.
Not investment advice.